Teysuno
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The 3+3 design is the method most commonly used to identify the maximum tolerated dose (MTD) and recommended dose for phase II…
© TOUCH MEDICAL MEDIA 2013 93 A satellite symposium, chaired by Eric Van Cutsem and Josep Tabernero, was held on the 3rd July…
S-1 (Teysuno®) is an oral anticancer agent comprising the 5-fluorouracil (5-FU) prodrug tegafur and targeted modulators…
Background: S-1 (Teysuno) is approved in Japan foradjuvant and palliative treatment of many gastro-intestinal (GI) malignancies…
Patients with advanced-stage gastric cancer and inoperable locoregional extension rarely survive more than a few months…
Karcinom žaludka je smrteľna choroba a je stale druha najcastejsia pricina umrti na rakovinu na celom svete. Chirurgický zakrok…
INTRODUCTION Gastric cancer is the fourth most common human malignancy worldwide, with upwards of 980,000 new cases per year…